Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001
<!-- Name:DistributionId Value:1000821558 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:5555 -->…